360 related articles for article (PubMed ID: 24520771)
1. [Research progress and prospect of universal influenza vaccine].
Luo DY; Xue CY; Cao YC
Bing Du Xue Bao; 2013 Nov; 29(6):646-50. PubMed ID: 24520771
[TBL] [Abstract][Full Text] [Related]
2. [Progress in new vaccine strategies against influenza: a review].
Liu Z; Jiang T; Qin E; Ran D; Qin C
Sheng Wu Gong Cheng Xue Bao; 2012 May; 28(5):550-6. PubMed ID: 22916493
[TBL] [Abstract][Full Text] [Related]
3. Tracking progress in universal influenza vaccine development.
Ostrowsky J; Arpey M; Moore K; Osterholm M; Friede M; Gordon J; Higgins D; Molto-Lopez J; Seals J; Bresee J
Curr Opin Virol; 2020 Feb; 40():28-36. PubMed ID: 32279026
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
[TBL] [Abstract][Full Text] [Related]
5. Toward a universal influenza virus vaccine: prospects and challenges.
Pica N; Palese P
Annu Rev Med; 2013; 64():189-202. PubMed ID: 23327522
[TBL] [Abstract][Full Text] [Related]
6. Universal influenza vaccines, a dream to be realized soon.
Zhang H; Wang L; Compans RW; Wang BZ
Viruses; 2014 Apr; 6(5):1974-91. PubMed ID: 24784572
[TBL] [Abstract][Full Text] [Related]
7. Development of universal influenza vaccines based on influenza virus M and NP genes.
Zheng M; Luo J; Chen Z
Infection; 2014 Apr; 42(2):251-62. PubMed ID: 24178189
[TBL] [Abstract][Full Text] [Related]
8. A Perspective on Nanoparticle Universal Influenza Vaccines.
Deng L; Wang BZ
ACS Infect Dis; 2018 Dec; 4(12):1656-1665. PubMed ID: 30394725
[TBL] [Abstract][Full Text] [Related]
9. Beyond clinical trials: Evolutionary and epidemiological considerations for development of a universal influenza vaccine.
Viboud C; Gostic K; Nelson MI; Price GE; Perofsky A; Sun K; Sequeira Trovão N; Cowling BJ; Epstein SL; Spiro DJ
PLoS Pathog; 2020 Sep; 16(9):e1008583. PubMed ID: 32970783
[TBL] [Abstract][Full Text] [Related]
10. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
Lei H; Peng X; Jiao H; Zhao D; Ouyang J
Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406
[TBL] [Abstract][Full Text] [Related]
11. [Progress in development of influenza virus-like particles].
Ge SQ; Wang ZL
Bing Du Xue Bao; 2013 Mar; 29(2):224-32. PubMed ID: 23757857
[TBL] [Abstract][Full Text] [Related]
12. The evolving history of influenza viruses and influenza vaccines.
Hannoun C
Expert Rev Vaccines; 2013 Sep; 12(9):1085-94. PubMed ID: 24024871
[TBL] [Abstract][Full Text] [Related]
13. Identification of effective constituents of influenza vaccine by immunization with plasmid DNAs encoding viral proteins.
Ze C; Kurata T; Tamura S
Jpn J Infect Dis; 2000 Dec; 53(6):219-28. PubMed ID: 11227019
[TBL] [Abstract][Full Text] [Related]
14. Genetic engineering of live attenuated influenza viruses.
Jin H; Chen Z; Liu J; Kemble G
Methods Mol Biol; 2012; 865():163-74. PubMed ID: 22528159
[TBL] [Abstract][Full Text] [Related]
15. Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice.
Wang W; Li R; Deng Y; Lu N; Chen H; Meng X; Wang W; Wang X; Yan K; Qi X; Zhang X; Xin W; Lu Z; Li X; Bian T; Gao Y; Tan W; Ruan L
Clin Vaccine Immunol; 2015 Jun; 22(6):618-30. PubMed ID: 25834017
[TBL] [Abstract][Full Text] [Related]
16. Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
Altenburg AF; Rimmelzwaan GF; de Vries RD
Vaccine; 2015 Jan; 33(4):500-6. PubMed ID: 25498210
[TBL] [Abstract][Full Text] [Related]
17. Immunization with baculovirus displayed H6 hemagglutinin vaccine protects mice against lethal H6 influenza virus challenge.
Musthaq SK; Kumar SR; Szyporta M; Kwang J
Antiviral Res; 2014 Sep; 109():42-53. PubMed ID: 24973759
[TBL] [Abstract][Full Text] [Related]
18. Influenza bivalent vaccine comprising recombinant H3 hemagglutinin (HA) and H1 HA containing replaced H3 hemagglutinin transmembrane domain exhibited improved heterosubtypic protection immunity in mice.
Liu Q; Xue C; Zheng J; Liu K; Wang Y; Wei Y; Liu GD; Cao Y
Vaccine; 2015 Jul; 33(32):4035-40. PubMed ID: 26100927
[TBL] [Abstract][Full Text] [Related]
19. Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine.
Jegaskanda S; Reading PC; Kent SJ
J Immunol; 2014 Jul; 193(2):469-75. PubMed ID: 24994909
[TBL] [Abstract][Full Text] [Related]
20. Research and development of universal influenza vaccines.
Du L; Zhou Y; Jiang S
Microbes Infect; 2010 Apr; 12(4):280-6. PubMed ID: 20079871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
